Early Detection of Parkinson’s Through Skin Swabs

Scientists have uncovered a promising noninvasive method to identify Parkinson’s disease years before symptoms emerge, using skin swabs to analyze sebum and scent markers.

Scientists may have found a new way to detect Parkinson’s early via skin swabs.

About the Study

Currently, Parkinson’s disease affects over 10 million people worldwide, with no cure or reliable early diagnostic tests. Drupad K. Trivedi and his team at the University of Manchester identified that skin swabs of sebum can reveal volatile organic compounds (VOCs) associated with Parkinson’s, which have distinct odors. This innovative approach could enable early, noninvasive diagnosis.

Smelling Signs of Parkinson’s

The research focused on analyzing sebum—the oily substance produced by skin glands—to detect VOCs that differ in individuals with Parkinson’s. These compounds can be linked to odors that are unique to each person. Trivedi’s team discovered specific compounds that appear in higher or lower levels in those with Parkinson’s, as well as in individuals with REM sleep behavior disorder, an early Parkinson’s indicator.

This research is an extension of prior studies that identified odor biomarkers linked to Parkinson’s, inspired by Joy Milne, a woman with hyperosmia, who could smell Parkinson’s on her husband years before diagnosis. Further validation came from studies showing trained dogs can detect Parkinson’s by smell.

Implications for Diagnosis and Disease Monitoring

The study involved 83 participants, including diagnosed Parkinson’s patients, healthy controls, and those with early warning signs. The findings indicated that sebum VOC profiles could predict disease progression, offering a pathway for early intervention.

Dr. Trivedi highlighted that early detection could lead to timely clinical testing and the development of therapies that slow disease progression. Long-term studies are planned to validate and refine this technique.

Sebum analysis over several years also shows potential for mapping disease advancement, providing insights into how Parkinson’s progresses and how treatments might be evaluated.

Expert Opinions

Neurologist Rocco DiPaola commented that this noninvasive method holds promise for identifying Parkinson’s before symptoms appear. While the approach is still in early stages, further research could lead to standardized tests that help diagnose and monitor Parkinson’s early.

Conclusion

This groundbreaking research opens new avenues for early detection and management of Parkinson’s disease, emphasizing the importance of innovative, noninvasive diagnostic tools.

---